Sitemap - 2006 - The California Stem Cell Report
San Jose Merc: 'It's Working.'
The Private Touch in ESC Research
The Stem Cell Race: How California is Like the Cobbler's Children...Sort Of
The Stem Cell Race: Singapore's $370 Million Biopolis
The Stem Cell Race: Underdogs, Singapore's Biopolis, China and the UK
'Fair Cures,' Lab Construction and CIRM
CIRM Scholar Produces Mouse Brain Finding
Major News Series on Stem Cells Coming Up in San Diego
Stem Cell Snippets: Donley, Lomax and Reed
Murder Mysteries and Stem Cells
CIRM Hires Top Facilities Exec
Wanted: CEO For Promising $3 Billion Giveaway Program
Hook Down in the Pearl of the Pacific
Newspapers Take a Whack or Two at CIRM
CIRM Watchdog Receives $100,000 Grant
Affordable Access to Stem Cell Cures Hits Hard Sledding
CIRM Moves to Clean Up Audit Issues
The Loss of CIRM's Friendly Critic in Sacramento
The LA Times' Reality Check on CIRM
Review of the CIRM Grants Ends Five Hours Early
Moral Seduction and CIRM's $24 Million Grant Giveaway
Looking Closely at CIRM's Disclosure Rules
The Folks Betting on CIRM BANs
Who Gets the Dough and Who Shares: CIRM Tackles IP, Grants and Even Office Space
ACT Press Releases and the NY Times
The Interests At Stake at the California Stem Cell Agency
CIRM's Own Best Interest Requires More Disclosure
CIRM Nearly Awash in Cash -- Sort Of
Industry Opposition to Affordable Stem Cell Therapies Deplorable
Biomedical Industry Says Nay to California Stem Cell Affordability
Cracking the Tap for Stem Cell Cash
CGS Package of Stem Cell Items
Major Conflicts of Interest, Picayune Details
Stem Cell Snippets: Galas to Free Stem Cell Movies
An Extraordinary Agency (CIRM), Now Two Years Old
Klein and the Endorsement: CIRM Says No Comment
Does Klein's Endorsement of a Political Candidate Violate the Law?
The Scientist Magazine: WARF Patents Over-Reaching
Klein Says $150 Million Loan Up for Approval Later This Month
Stem Cell Politics: Beware the ESC Troglodytes
$150 Million Snared in 'Red Tape'?
Missing: Arnold's Promised $150 Million Stem Cell Loan
Welcome to The Biopolitical Times
Stem Cell Snippets: Warehouses, Fox Ad and Pombo
Arlington Speaks on CIRM's Orphan Software
Death of CIRM Software Firm Only a 'Hiccup'
The $25 Million Bioethicists' Dog
Klein Helps Aussies in Stem Cell Fray
Stem Cell Snippets: Conflicts, WARF and Politics
Stem Cell Snippets: Rentals to DNA
SEED Grant Hopefuls Total 232; Names Remain Secret
SEED Grant Applications Pour Into CIRM
Doggie Bag Tidbits from the CIRM Meeting
Stem Cell Snippets: UC Irvine, Loring and Windows of Opportunity
Stem Cell Snippets: From WARF to Researcher Conflicts
Stem Cell News Coverage: Spending, Geography and Planning
Conflicts of Interest: From Press Releases to Matching Funds
Few Complaints Voiced on CIRM Strategic Plan
Some Aussies Less Than Enthusiastic About CIRM Plan
Wisconsin Gives $1 Million to Thomson Firm, More Tidbits on WARF Patent Flap
CIRM to California: Lower Your Expectations
Text of Statements from CGS on Politics of Stem Cell Research
A Chockablock Stem Cell Agenda and Poetry
San Diego Stem Cell Researchers Enthused by CIRM Plan
The NY Times on CIRM's Proposed Spending Plan
More Comment on CIRM's Strategic Plan
CIRM Posts Draft of Strategic Plan
A Quick Look At Who is Covering CIRM's Plan Today
Some Unhappy with CIRM's Strategic Plan
More Details on CIRM's Strategic Plan
Executive Summary of CIRM Strategic Plan Draft
CIRM's Draft Plan Calls for $463 Million to Push Stem Cells into Clinics
Feds Say 'Substantial Question' Exists on WARF Patents
Rules Approved for Millions in Lab Grants
Read All About It! At Least Some Of It
Whittling Down the Researchers: The 'Unhappy' Result of Stem Cell Enthusiasm
Wisconsin Rachets Up Its Stem Cell Pitch
Two Days and Two Very Different Stem Cell Conversations
Kleffman's Coverage on Egg Risk is First Out of the Cyberspace Gate
Scientists Call for More Study of Egg Donation Effects
Multimillion Dollar Stem Cell Lab Building Program: The First Step
Egg Donation: 'People Think You Just Go In and Grab Some'
Ortiz Legislation to Protect Egg Donors Signed Into Law
Live Webcast Set for CIRM Egg Donation Conference Thursday
More Attention Needed to Public Needs in Stem Cell Research
Governor's Press Release on Azziz
LA Doc Named to CIRM Oversight Committee
Watchdog Group Praises CIRM IP Task Force
Stem Cell Snippets: Sherry Lansing to Stanford Freebies
Open Access: Time to Catch the Wave
IP Policy for Business Moves on to Final Step
Secrecy Broken on CIRM Grant Applicants
CIRM Defends Secrecy on Grant Letters of Intent
CIRM Grant Program Stimulates More Comment
CFAC Says Applicant Secrecy is Bad Policy
Sunshine Needed on the Secret Names of Stem Cell Grant Applicants
More Tidbits on Eggan and the MacArthur...and a CIRM IP Note
UC Officials Call for Open Access to Taxpayer Financed Stem Cell Research
CIRM Working Group Member Wins a MacArthur
News Briefing Tomorrow on Stem Cell Issues
Hundreds of Millions at Stake? Draft CIRM IP Policy for Business Now Available
Love and Reed Mentioned in Massachusetts Political Coverage
'Desperate Companies, Delusional Researchers'
CIRM's Financial Watchdogs Vote for Disclosure
FTCR: Lockyer Should Dump CIRM Financial Overseer
Stem Cell IP for Business Coming Up on Thursday
Stem Cell Research Regulations Up Next Week -- But Not CIRM's
Latest on Legal Qualifications of CIRM Financial Overseer
Text from ACT's Ethics Chair to U.S. Senate Subcommittee
Text From Lanza's U.S. Senate Appearance
Feds Could Take Up WARF Stem Cell Patent Dispute Next Month
FTCR: Hein Should Resign from Stem Cell Panel
The Unexpectedly (to some) Long Life of CIRM
Update on Legal Actions Against CIRM
Another Reason for Public Disclosure by CIRM Grant Reviewers
Stem Cell Snippets: Starters to Strategic Planning
No Time to Weaken 'Second Level of Oversight'
Senators Scold Visibily Shaken Lanza
New CIRM Auditor Sought in Wake of Copying Flap
Stem Cell Snippets: Cibelli, IP and Davey
CIRM's Financial Practices to be Reviewed Next Week
The Hooha Over ACT: A Case Study in Stem Cell PR
The Thinking on the Sole Negative Vote on the Egg Donor Bill
Ortiz' Legislation to Protect Egg Donors Goes to Governor
"Pay the Ladies, Please," Say Two From Academe
CIRM IP Group Changes Research Usage Exemption
CIRM IP Policy and Business: New Principles Approved
A 'Good Citizen" Research Exemption
Text of Nonprofit IP Comments Now Available
ACT, CIRM and the Test of Time
California Biomed Still Concerned About CIRM IP
Somewhat Differing Views On ACT
Stem Cell Snippets: Interviews to IP
After the Lights Go Out at CIRM
CIRM Replies Re Public Disclosure by Grant Reviewers
Stem Cell Stocks Jump on ACT News
Rules for the $100 Million Stem Cell Giveaway
The Scientist Magazine: CIRM, Disclosure and Conflicts
FTCR: CIRM May be Moving Too Hastily
IP Principles for Business Coming Up Next Week
More State Oversight of CIRM Not Likely
On to the Deadly Vizcaino Plain
CIRM Hires Senior Communications Executive
Forbes on Private Stem Cell Giving
CIRM to Examine 'Outline' of $3 Billion Giveaway
Wrapping up the Private Giving to CIRM
Gritty, Gritty Details on CIRM's Planning Process
Calling the Tune on ESC Research: Therapies or Tools?
Does Disclosure Mean Only the Second Tier Will Play?
Patient Advocates: More Collaboration Needed, Risky Ventures Okay
Stem Cell Conferences: Eggs, Biocapital and Fair Cures
Finding Stem Cell Moolah on the Web
Money Talks in Connecticut Too
CIRM Oversight Legislation Set for Thursday Hearing
Proposal to Tighten CIRM Oversight Coming Up Next Week
Stem Cell Alliance Shutting Down
The Immune Feeling of Researchers to Conflicts of Interest
Clinical Stem Cell Research: Financing and Academic Medical Centers
Reflections on Stem Cells: Year Five
Heifer Blitzes Stem Cell Coverage
CIRM Approves $150 Million Grant Program
CIRM Press Release on Grant Program
From Dollar Signs to Stem Cells: Diverging Views on WARF Patents
NY Times: Stem Cell Research Funding 'Fairly Robust'...Or Is It?
San Jose Merc: Full Disclosure Needed from CIRM
Stem Cell Snippets: Brits, Maryland and Defining the Debate
Busy Agenda for CIRM Oversight Committee in August
Anchors Aweigh for the California Stem Cell Report
Ortiz Measure Stripped of Ban on Reimbursement of Lost Wages
Stem Cell Snippets: Hear Arnold and Jesse
CIRM Guide to Comments on IP Rules
The $150 Million CIRM Bailout, Politics and Oversight
Hard Data: Stem Cell Researchers Looking to California and Abroad
WARF Patent Challenge Coverage: More Likely to Come
Veto to Hinder California Stem Cell Research
R&D Stem Cell Session in San Francisco Tuesday
Industry-supported Changes in IP Rules Face August Action
WARF Patents Under Renewed Assault
CIRM Spawns 'New Life' -- Partly
WSJ Highlights Research Conflicts of Interest
Stanford's Rationale for Release of Conflict Info
Stanford University: Medical Research, Money and Conflicts of Interest
California AG Moving Against CIRM Foes
Stem Cell Research and Bringing Camels into the Tent
UC Irvine Looking for CIRM Grant
WARF Smacks Stem Cell Watchdog
Stem Cell Legal: Fishing for Another Judgment
Business To CIRM: We Need More Money
Stanford Bioethicist Says More Monitoring Needed on California Stem Cell Research
Protection of Egg Donors Heading for Governor's Desk
China No. 1 on ESC Spending, except for California?
Correction on CIRM Firing Policy
"Good" Audit, Poor Cooperation at CIRM
Black Leaves Oversight Committee
Looking Inside CIRM's Planning
CIRM's Strategic Plan: A Guide (v1.0) to Planning Documents
CIRM Strategic Planning: The Questions Being Asked
Still Simmering: The Two-Boss Brew at CIRM
CIRM and WARF are Talking Patents
Dateline Juncalito: News for Blog Geeks Only
CIRM News Coverage: Inertia, Limits and Business-as-Usual
Background Statement from Americans for Stem Cell Therapies and Cures
Google Ranks California Stem Cell Report No. 4
Klein's Letter Helps Build CIRM Legacy -- Unfortunately
DHS Stem Cell Advisory Committee to Sunset
Correction on Gala Donor Names
Watchdog Says CIRM 'Laundering' Cash
Klein to Ortiz: You Are an "Ongoing Threat"
Klein and the Facts of The Matter
Text of the Klein-Ortiz-SB401 Letter
CIRM's Strategic Plan Interviewees
More Fresh Stuff on CIRM Planning
Klein Still Hard on the Money Trail
Time for Tougher Disclosure on Working Groups
California Stem Cell Research Regulation: CIRM is Not the Only Player
Can CIRM Help Reduce Health Care Costs?
CGS: Democrats Over The Top on Stem Cell Research
Stem Cell Advocacy Conference at Stanford
"Dualing" Execs at CIRM: Touchy Issues Between Klein and Hall
Klein Caught in Stem Cell Blow-back
Ortiz' CIRM Bill Delayed Until August
BioCentury: NIH Looking Korean Stem Cell Lines
Uncertainty and the Ostensible Stem Cell Swag
Looking at Legislation to Aid Biotech Biz
WARF to CIRM: Don't Mess With Us
Stem Cell Snippets: Swells, Scholars and Door Knockers
The Chronicle Calls for SB401 Compromise
Legislation, Budget and More on Oversight Committee Table June 2
Devising a Plan for a Multi-Billion Dollar Project: The CIRM Approach
Stem Cell Snippets: Liberal Folly, WARF and SB401
CIRM Meeting Documents Posted in Timely Fashion
Ortiz Drops Critical Elements from CIRM Oversight Bill
Stem Cell Snippets: Eggs, Cloning, David Baltimore
CGS Criticizes CIRM Fundraising
Big Week Ahead for Legislative Move to Tighten Stem Cell Oversight
Mary Poppins' Latest Position on CIRM Gala
ACT Reports its Cloning Efforts
Chron First on Embryo Cloning Story
Gala Disclosure Mere Lip Service
WSJ Reports on Embryo Cloning in California
California Stem Cell News Links
California Newspapers Opine on CIRM and Trial Decision
A Look at a Key CIRM Planning Document
Egg Donor Protection Advances in State Senate
Readers Write: Commentary on the Legal 'Charade'
Gala Donor Names to be Disclosed; Mary Poppins Would Approve
Leveraging a $3 Billion Stem Cell Giveaway
Wisconsin Pushing Hard on Stem Cell Research
San Diego Session On Sharing Stem Cell Swag
Greed, Giveaways and the Public
California vs. Wisconsin: Dangerous Monopoly?
Social Justice Stem Cell Conference at UC San Diego
CIRM Fends Off Legal Challenge; Round Two Coming Up
Klein's Exercise in Stem Cell Sophistry
Stem Cell Hard Ball Under the Dome
More Disclosure Needed in $1 Million CIRM Gala
Eyewitness Legislative View from Stem Cell Advocate
Effort Advances to Beef Up Royalties and Oversight of CIRM
Stem Cell Firms Not Bargaining on IP From Strong Position
Still Time to be Heard on Stem Cell Ethics and Conflict Rules
Excerpts from Loring's "Daunting" Article
$1 million CIRM Fundraiser Stirs Critics
Release of Stem Cell Cash Generates Generally Positive Coverage
Biotech Industry Exec Latest Appointee to CIRM Oversight Committee
Ortiz Pushing CIRM on Conflicts and Openness
The $500,000 Plan to Spend $3 Billion
Zoloth Speaking Monday at UC Santa Cruz
Alliance for Stem Cell Research Beefs Up Web Site
CIRM Garners Greenbacks and Flack From Critics
Angelides Makes Minor Stem Cell Hay
Naming Rights: Selling Out to Biotech?
Stem Cell Industry Resists Strings on CIRM Grants
Democratic Candidates to Vote on CIRM Funding
CIRM's Coffers Not Looking So Bare
An Examination of CIRM's Autonomy
Watchdog Group: No Invention Ownership for Businesses
Formulating a Plan to Give Away $3 Billion
Color the News Stem Cell Green
WARF Under Assault For Excessive Royalties
Can WARF Collect Stem Cell Royalties From California?
ACT's Caldwell Responds to 'Unease' Item on State Funding of Stem Cell Research
Stem Cell Research Chain Larded With Cash Except for Women Egg Donors
CIRM Tackles IP Rules for Private Business March 29
Altruism Won't Supply Enough Eggs and Other News From UCLA
California Should Expect Modest Royalties From Stem Cell Firms
Demons, Disease and Stem Cells
$50 Million for CIRM: All But In The Bag
The End to The Stem Cell Meeting
Wisconsin to CIRM: Cough Up Some Cash
Warnings about Overhyping Stem Cell Science
No Teleconferencing for Research Working Group Meeting
The New, Obscure Run at California Stem Cell Research Guidelines
The California Stem Cell Trial: 'Purely Political'
Penultimate Clashes in the Stem Trial
Four Stem Cell Biggies Form Consortium
Los Angeles Readers Told of Stem Cell 'Silliness'
CIRM Faces State Performance Audit
CIRM: Remarkable But a State Budgetary Wisp
CIRM Makes "Progress" Says Monitor
Public Embryo Bank Started at Secret San Diego Location
The Stem Cell Trial: A View From an Advocate
IP Policy for Business Upcoming Along With Grants Rules
The Stem Cell Trial: 'Reaching for The Water Pitcher'
Chron Story on Stem Cell Trial
Stem Cell Trial Coverage and Silent Testimony
Weak Case Made by CIRM Opponents
Stem Cell Trial Recesses for Lunch
Klein Testifying About State Control of CIRM
Foes Probe Conflicts of Interest
Stem Cell Trial Resumes This Morning
Fumbling Marks First Day of Stem Cell Trial
CIRM On The Mark With Media Info
Stem Cell Ethics Rules "Flawed"
CHI, Stem Cells, Love and Morrow
Stem Cell Audit Proposal Delayed
$25 Million for Stem Cell Research and Other Stuff at USC
Frankenstein, Train Wreck or Good Listener?
Ortiz Seeks Performance Audit of CIRM; Westly Says "Tough Oversight" Needed
Major Stem Cell Conference Scheduled for March 2-4 at UC Berkeley
Clashing Interests on the Stem Cell Oversight Committee
Human Tidbits Amid Stem Cell Policy
Valentine's Day Editorials on CIRM
What's in a Name? Ten Million Dollars or More
CIRM-UK Stem Cell Conference Later This Year
Klein Confirms $40 Million Commitment
Ortiz Not Satisfied with Egg Expense Rules
Ethics and IP Coverage Mostly Favorable To CIRM
Research and IP Policies Clear Oversight Committee
Text of CIRM News Release on Approval of IP and Research Policies
Cryptic Agenda Not Good Enough
Does CIRM Have a "Secret" Proposal on Openness?
Disclosure From the California Stem Cell Report
Are Women Ready to Donate Their Eggs for 'Nothing?'
Free Parking for Friday CIRM Meeting
CIRM and the $40 Million Matter
Latest Version of Stem Cell IP Policy Ready
Disclosure of Researchers' Financial Interests to Subjects Recommended
Light Coverage of Stem Cell Research Standards
Can the Research Standards be Policed?
Bee Reports Tersely on CIRM Research Standards
CIRM Readying Egg Donor Protections
Standards Meeting Report from the Alliance for Stem Cell Research
A Report from a Patient Advocate on Today's Ethics Meeting
Ortiz Praises Proposed IP Policies -- With Caveats
Text of Ortiz Letter to Klein, Penhoet
CIRM: Moon Shot or Cautionary Tale or Both?
New Link Added: Stemcellbattles.com
Policy for Removal of Stem Cell Advisers Advances
CIRM Hires Sacramento Lobbyist for Another Three Months
CIRM Nearing Final Action on Ethics and Research Standards
The Stem Cell Agenda of a State Senator
Light Coverage of Stem Cell IP Decisions
Confirmed: $40 Million Raised for CIRM
Revenue and Results Sharing Plus More March-In
Patenting, Access to Research Materials and Therapies: A Commentary
Rival IP Proposal From Watchdog Groups
Lots of News on CIRM on Monday
Chron Carries Bleak Story About CIRM
FTCR: CIRM Highhanded and Stonewalling
New York's Carlyle Hotel and California IP Hearing: Planning on Attending?
Researcher Cibelli Quits California Stem Cell Agency
CIRM IP Plans: The 25 Percent Solution for the Golden State
More on the Mystery of The Bonds
CCST IP Report Smacked for Short-changing State
Prop. 71 Inspiring "Awe" Elsewhere
Coverage of the Call for Klein's Resignation
Ortiz Calls for More CIRM Accountability
Quick Look at Coverage of Stem Cell Report Card
CGS: CIRM Turns in Mediocre Performance; Klein Should Quit
IP Report: More Sharing of Stem Cell Research Results
LA Times on Cirm: Disappointing, Arrogant, Unresponsive, But Promise Remains Strong
CIRM and Stem Cell IP Hearings: A Cold Shoulder to the Public
Big Stem Cell Soiree Scheduled For San Francisco
The Financial Message on Stem Cell Research
California Stem Cell Research: Hype, Folly and Contempt?
Bioethics Blog Disagrees with CIRM Exec
Chronicle: CIRM Needs Careful Regulation
New Money-Raising Effort at CIRM
CIRM, Cibelli, Korea and The Bee
California Pushing Ahead with Cloning ESC
Hwang Reaction: Research Needs More Care
CIRM Promises Open Search on General Counsel
Update on CIRM's General Counsel: An Orrick Connection
Time for a Stem Cell Sunshine Vaccine
Studying the Science of Surfing
California Researchers Forging Ahead with SCNT -- Among Others
San Diego Voice: Don't Tar California Stem Cell Effort
Wilson Cites Other Commitments
Gayle Wilson Leaves Oversight Committee
Eggs, Ethics and Cash: What about Singapore?
CIRM President On Cyberspace Airwaves Jan. 4
California Universities Not Waiting for CIRM Cash